Left Ventricular Conduction Delays and Relation to QRS Configuration in Patients With Left Ventricular Dysfunction

Left ventricular activation delay (LVAT) > 100 ms may determine response to cardiac resynchronization therapy, but its prevalence and relation to QRS configuration are unknown. QRS duration and LVAT in control subjects (n = 30) were compared with those in patients with heart failure (HF; LV ejection fraction 23 +/- 8%, n = 120) with a QRS duration <120 ms (NQRS(HF), n = 35) or >= 120 ms (left bundle branch block [LBBBHF], n = 54; right bundle branch block [RBBBHF], n = 31). LVAT was estimated by interval from QRS onset to basal inferolateral LV depolarization. In controls, QRS duration was 82 +/- 13 ms and LVAT was 55 18 ms. LVAT was always < 100 ms. In patients with NQRS(HF), QRS duration (104 10 ms) and LVAT (82 22 ms) were prolonged versus controls (p <0.001). LVAT exceeded 100 ms in 8 of 35 patients. In patients with LBBBHF, QRS duration (161 +/- 29 ms) and LVAT (136 +/- 33 ms) were prolonged compared with controls and patients with NQRS(HF) (P <0.001). LVAT exceeded 100 ms in 47 of 54 patients. In patients with RBBBHF, QRS duration did not differ from that in patients with LBBBHF, but LVAT (100 +/- 24 ms) was shorter (p <0.001). In 17 of 31 patients with RBBBHF LVAT was < 100 ms; (82 +/- 12), similar to those with NQRS(HF) (P = NS), indicating no LV conduction delay. However, in 7 of 31, LVAT (135 +/- 13 ms) was similar to that in patients with LBBBHF (P = NS). LVAT correlation with QRS duration varied (control p = 0.004, NQRS(HF) P = 0.15, RBBBHF P = 0.01, LBBBHF P <0.001). In conclusion, LV conduction delays in patients with HF varied with QRS configuration and duration, exceeding 100 ms in only 23% of patients with narrow QRS configuration and 45% with RBBBHF compared with 87% with LBBBHF. Fewer than 25% of patients with RBBBHF demonstrated delays equivalent to those in patients with LBBBHF. These variations may affect efficacy to cardiac resynchronization therapy. (C) 2009 Elsevier Inc. All rights reserved. (Am J Cardiol 2009;103:1578-1585)